Financial reports
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
2 Mar 22
Current reports
8-K
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Verrica Pharmaceuticals Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Regulation FD Disclosure
27 Jul 23
8-K
Verrica Pharmaceuticals Announces Closing of $125 Million Debt Financing with OrbiMed
26 Jul 23
8-K
Regulation FD Disclosure
24 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
8 Jun 23
8-K
Verrica Pharmaceuticals Reports First Quarter 2023 Financial Results
9 May 23
8-K
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results
6 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
9 May 23
424B5
Prospectus supplement for primary offering
22 Feb 23
FWP
Free writing prospectus
21 Feb 23
424B5
Prospectus supplement for primary offering
19 Dec 22
S-3
Shelf registration
7 Nov 22
424B5
Prospectus supplement for primary offering
1 Jul 22
424B5
Prospectus supplement for primary offering
29 Jun 22
S-8
Registration of securities for employees
9 May 22
S-8
Registration of securities for employees
7 May 21
424B5
Prospectus supplement for primary offering
23 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEF 14A
Definitive proxy
22 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
DEFA14A
Additional proxy soliciting materials
25 Apr 19
DEF 14A
Definitive proxy
25 Apr 19
Other
EFFECT
Notice of effectiveness
20 Dec 22
CORRESP
Correspondence with SEC
15 Dec 22
UPLOAD
Letter from SEC
29 Nov 22
CORRESP
Correspondence with SEC
18 Nov 22
UPLOAD
Letter from SEC
15 Nov 22
UPLOAD
Letter from SEC
8 Nov 22
SEC STAFF
SEC staff action: Order
19 Apr 21
SEC STAFF
SEC staff action: Order
22 Mar 21
EFFECT
Notice of effectiveness
26 Mar 20
CORRESP
Correspondence with SEC
23 Mar 20
Ownership
4
Christopher G. Hayes
19 Mar 24
4
Gary Goldenberg
19 Mar 24
4
Terry Kohler
19 Mar 24
4
Joe Bonaccorso
19 Mar 24
4
Ted White
19 Mar 24
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G
Avoro Capital Advisors LLC
14 Feb 24
4
JOSEPH EDELMAN
29 Dec 23
4
JOSEPH EDELMAN
26 Dec 23
4
JOSEPH EDELMAN
19 Dec 23